Obiettivo Retinal degenerations are a major cause of blindness in the European Union. The aim of this proposal is to develop somatic gene therapy for these conditions. The central issue which must be addressed is the safe and efficient delivery of therapeutic genes to photoreceptor cells. In this proposal we aim to improve our delivery system and assess its efficacy in an animal model. Campo scientifico medical and health sciencesmedical biotechnologygenetic engineeringgene therapymedical and health sciencesclinical medicineophthalmology Programma(i) FP5-LIFE QUALITY - Specific Programme for research, technological development and demonstration on "Quality of life and management of living resources", 1998-2002 Argomento(i) 1.1.1.-3. - Key action The "Cell factory" Invito a presentare proposte Data not available Meccanismo di finanziamento RGI - Research grants (individual fellowships) Coordinatore UNIVERSITY COLLEGE LONDON Contributo UE Nessun dato Indirizzo Bath Street 11-43 EC1V 9EL LONDON Regno Unito Mostra sulla mappa Costo totale Nessun dato
